We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Montelukast Sodium Chewable Tablets 4mg (Camber, USA)
Section 19A approved medicine
Montelukast Sodium Chewable Tablets 4mg (Camber, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
APX-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet blister pack - ARTG 184831
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack - ARTG 184837
MONTELUKAST SANDOZ 4 montelukast 4 mg (as sodium) chewable tablet blister pack - ARTG 184832
MONTELAIR 4 montelukast 4 mg (as sodium) chewable tablet blister pack - ARTG 184837
MONTELUKAST SANDOZ 4 montelukast 4 mg (as sodium) chewable tablet blister pack - ARTG 184832
Indication(s)
- Prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older.
- Symptomatic treatment of seasonal allergic rhinitis.
Images
